6-Methoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)quinazolin-4(3h)-one

Catalog No. :
ACYJZW637
CAS No. :
1312008-08-4
Molecular Formula :
C20H22N4O2
Molecular Weight :
350.42

IUPAC Name:6-methoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)quinazolin-4(3H)-one

6-Methoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)quinazolin-4(3h)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)quinazolin-4(3h)-one
IUPAC Name6-methoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)quinazolin-4(3H)-one
MDL No.MFCD13196683
Molecular FormulaC20H22N4O2
Molecular Weight350.42
SMILESO=C1NC(C2=CC=C(N3CCN(C)CC3)C=C2)=NC4=C1C=C(OC)C=C4
InChI KeyWJLYJMKSCOZXJG-UHFFFAOYSA-N
Synonym6-methoxy-2-[4-(4-methyl-1-piperazinyl)phenyl]-4(3H)-Quinazolinone;4(3H)-Quinazolinone, 6-methoxy-2-[4-(4-methyl-1-piperazinyl)phenyl]-
CAS No.1312008-08-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYJZW637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYEZM921 route compound structure diagram
    ACYEZM92127913-99-1 In Stock
  2. Plus
  3. ACOFHE234 route compound structure diagram
    ACOFHE2341882-71-9 In Stock
  4. Then
  5. ACYJZW637 route product structure diagram
    ACYJZW6371312008-08-4
Inquiry

2. ACYJZW637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYJZW637 route product structure diagram
    ACYJZW6371312008-08-4
Inquiry

Comments (0)